2025-03-12
This in-depth analysis covers the entire SNP detection kit development process, from disease target screening (GWAS/ClinVar databases), technology selection (qPCR/NGS/arrays), clinical sample validation, and Class III medical device filing. This section covers high-throughput assay optimization, anti-interference testing, and regulatory compliance.